 | The Alpha variant (B.1.1.7) was a SARS-CoV-2 variant of concern. It was estimated to be 40–80% more transmissible than the wild-type SARS-CoV-2 (with most... 219 KB (18,220 words) - 23:46, 31 March 2024 |
| Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are viruses that, while similar to the original, have genetic changes that are... 228 KB (20,969 words) - 03:47, 28 April 2024 |
| Omicron (B.1.1.529) is a variant of SARS-CoV-2 first reported to the World Health Organization (WHO) by the Network for Genomics Surveillance in South... 207 KB (23,819 words) - 16:45, 15 April 2024 |
COVID-19 vaccine (redirect from Sars cov 2 vaccine) acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19). Prior to... 192 KB (21,930 words) - 19:29, 15 April 2024 |
| COVID-19 testing (category CS1 foreign language sources (ISO 639-2)) involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main types of tests detect either the presence of the virus or... 183 KB (21,153 words) - 08:45, 17 April 2024 |
 | disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019... 285 KB (32,672 words) - 14:17, 28 April 2024 |
| 2020, a new SARS‑CoV‑2 variant, the Alpha variant or lineage B.1.1.7, was identified in the UK. Early results suggest protection to the variant from the... 98 KB (20,593 words) - 02:58, 8 March 2024 |
 | COVID‑19 vaccine is used to provide protection against infection by the SARS-CoV-2 virus in order to prevent COVID-19 in adults aged 18 years and older.... 211 KB (16,862 words) - 19:31, 11 March 2024 |
| COVID-19 pandemic in Europe (category CS1 foreign language sources (ISO 639-2)) Retrieved 11 January 2021. "New COVID-19 Variant in the UK". gov.uk/government/collections/new-sars-cov-2-variant. Retrieved 11 January 2021. "Approval by... 201 KB (22,526 words) - 09:50, 28 March 2024 |
vaccine developed by Sanofi Pasteur and GSK plc. It is based on the SARS-CoV-2 Beta variant. EMA countries (as booster only) Austria Belgium Bulgaria Croatia... 318 KB (19,351 words) - 20:00, 21 April 2024 |
 | J, Comeau JL, Li W, et al. (October 2020). "Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic... 231 KB (25,180 words) - 01:22, 4 April 2024 |
on orange background Service vehicle (S) – white on turquoise Unusual variant(s) – yellow symbols on red background 1963 Standard format – white symbols... 103 KB (3,657 words) - 11:35, 27 April 2024 |
 | Monkeypox virus (section Variants and clades) virusres.2022.198932. PMC 9534104. PMID 36165924. Shchelkunov SN, Totmenin AV, Babkin IV, Safronov PF, Ryazankina OI, Petrov NA, et al. (November 2001)... 29 KB (3,625 words) - 16:28, 27 April 2024 |